Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy; D002339:Carotid Arteries / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005080:Exercise Test; D005132:Eye Manifestations / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use*; D012160:Retina; D014652:Vascular Diseases / Q000188:drug therapy*; D014717:Vertigo / Q000188:drug therapy; D014785:Vision, Ocular / Q000187:drug effects
D000924:Anticholesteremic Agents; D011422:Propionates; D010417:Pentaerythritol Tetranitrate; D002784:Cholesterol